SARS-CoV-2, kokoana-hloko e bakang COVID-19, e bile le phello e kholo bophelong ba batho lefatšeng ka bophara;ho tšoaetsa batho ba bangata;ho baka lefu le matla le sequelae tse amanang le bophelo bo botle ba nako e telele;ho bakang lefu le ho shoa ho feteletseng, haholo-holo har'a batho ba hōlileng le ba tlokotsing;ho sitisa litšebeletso tsa kamehla tsa tlhokomelo ea bophelo;ho sitisa litšebeletso tsa kamehla tsa tlhokomelo ea bophelo;tšitiso ea maeto, khoebo, thuto le mesebetsi e meng e mengata ea sechaba;le ho ba le phello e mpe bophelong ba batho 'meleng le kelellong.

Mefuta e fapaneng ea liphatsa tsa lefutso ea SARS-CoV-2 e ntse e hlaha le ho potoloha lefats'e ho pholletsa le seoa sa COVID-19.

Bakeng sa ho lemoha leboitsebisoea mefuta e fapaneng ho tsoa UK, Brazil, Afrika Boroa le India, bo-ramahlale ba Foregene ba ba etselitse lisebelisoa tse ncha tsa ho lemoha.

Kit ena e sebelisa Real-time RT PCR technology (rRT-PCR) bakeng sa ho lemoha boleng ba SARS-CoV-2 le identification variant lineages nucleic acids in human nasopharyngeal or oropharyngeal swab samples, tse kang SARS-CoV-2 B.1.1.7 lineage (UK), B.1.351 lineage (BBR.1 line) (BBR.1 line).

Foregene SARS-CoV-2 Variant kit e na le tlholisano haholo , Ha e bapisoa le Brand e 'ngoe, Kit ea rona ha e hloke ho sebelisa lisebelisoa le sistimi ea nucleic acid, re ka sebelisa theknoloji ea rona ea Direct PCR (mohato o le mong) ho fumana le ho tsebahatsa mofuta o fetotseng SARS-CoV-2 B.1.1.7 leloko (UK), B.1. leloko (BR).kapele .

Letoto la lihlahisoa

Hona joale lisebelisoa tsena tsa letoto li amohetsoe ke litsi tsa liteko tsa Morocco, li lebelletse ho sebelisana le barekisi ba bacha ba tsoang lefats'eng lohle.

Mefuta e fapaneng ea SARS-CoV-2 le libaka tse fetotsoeng